...
首页> 外文期刊>Cancer immunology, immunotherapy : >A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells
【24h】

A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells

机译:通过B1细胞生产的保护性天然肿瘤反应性IgM生产需要TLR4-TRIF依赖性信号通路

获取原文
获取原文并翻译 | 示例
           

摘要

Metastatic cancer involving spread to the peritoneal cavity is referred to as peritoneal carcinomatosis and has a very poor prognosis. Our previous studies demonstrated a toll-like receptor 4 (TLR4) and C-type lectin receptor (CLR; Mincle/MCL) agonist pairing of monophosphoryl lipid A (MPL) and trehalose-6,6 '-dicorynomycolate (TDCM) effectively inhibits peritoneal tumor growth and ascites development through a mechanism dependent upon B1a cell-produced natural IgM, complement, and phagocytes. In the current study, we investigated the requirement for TLR4 and Fc receptor common gamma chain (FcR gamma), required for Mincle/MCL signaling, in the MPL/TDCM-elicited response. MPL/TDCM significantly increased macrophages and Ly6C(hi) monocytes in the peritoneal cavity of both TLR4(-/-) and FcR gamma(-/-) mice, suggesting redundancy in the signals required for monocyte/macrophage recruitment. However, B1 cell activation, antibody secreting cell differentiation, and tumor-reactive IgM production were defective in TLR4(-/-), but not FcR gamma(-/-) mice. TRIF was required for production of IgM reactive against tumor- and mucin-related antigens, but not phosphorylcholine, whereas TLR4 was required for production of both types of reactivities. Consistent with this, B1 cells lacking TLR4 or TRIF did not proliferate or differentiate into tumor-reactive IgM-producing cells in vitro and did not reconstitute MPL/TDCM-dependent protection against peritoneal carcinomatosis in CD19(-/-) mice. Our results indicate a TLR4/TRIF-dependent pathway is required by B1 cells for MPL/TDCM-elicited production of protective tumor-reactive natural IgM. The dependency on TRIF signaling for tumor-reactive, but not phosphorylcholine-reactive, IgM production reveals unexpected heterogeneity in TLR4-dependent regulation of natural IgM production, thereby highlighting important differences to consider when designing vaccines or therapies targeting these specificities.
机译:转移癌扩散到腹膜腔称为腹膜癌病,预后极差。我们之前的研究表明,toll样受体4(TLR4)和C型凝集素受体(CLR;Mincle/MCL)激动剂一磷酸脂质a(MPL)和海藻糖-6,6'-二谷氨酸(TDCM)通过依赖于B1a细胞产生的天然IgM、补体和吞噬细胞的机制,有效抑制腹膜肿瘤生长和腹水形成。在目前的研究中,我们调查了在MPL/TDCM诱导的反应中,Mincle/MCL信号所需的TLR4和Fc受体共同γ链(FcRγ)的需求。MPL/TDCM显著增加TLR4(-/-)和FcRγ(-/-)小鼠腹腔中的巨噬细胞和Ly6C(hi)单核细胞,表明单核细胞/巨噬细胞募集所需的信号冗余。然而,在TLR4(-/-)小鼠中,B1细胞活化、抗体分泌细胞分化和肿瘤反应性IgM产生存在缺陷,而FcRγ(-/-)小鼠则没有。TRIF是产生针对肿瘤和粘蛋白相关抗原的IgM反应所必需的,但不是磷酰胆碱,而TLR4是产生这两种反应所必需的。与此一致的是,缺乏TLR4或TRIF的B1细胞在体外不能增殖或分化为产生肿瘤反应性IgM的细胞,也不能在CD19(-/-)小鼠中重建MPL/TDCM依赖性的腹膜癌保护。我们的结果表明,B1细胞需要一条TLR4/TRIF依赖的途径,以使MPL/TDCM诱导产生保护性肿瘤反应性天然IgM。TrIF信号转导对肿瘤反应性的依赖性,而不是磷酸胆碱反应性,IgM的产生揭示了TLR4依赖性调节天然IgM产生的意想不到的异质性,从而突出了当设计针对这些特异性的疫苗或治疗时要考虑的重要差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号